Literature DB >> 10473581

A secreted form of the major histocompatibility complex class II-associated invariant chain inhibiting T cell activation.

E E Eynon1, C Schlax, J Pieters.   

Abstract

Major histocompatibility complex (MHC) class II molecules function at the cell surface to present antigenic peptides to T helper cells. Intracellularly, MHC class II molecules are associated with the invariant chain (Ii). Ii can modulate MHC class II-dependent T cell activation through (i) assistance in the export of MHC class II molecules from the endoplasmic reticulum, (ii) providing a targeting signal for endosomal/lysosomal compartments, and (iii) preventing peptides from associating prematurely with MHC class II molecules. Here we describe the generation and subsequent secretion of a lumenal form of Ii, IiP25. IiP25 lacked the targeting sequences for transport to MHC class II compartments but contained part of the CLIP region that is known to compete with antigenic peptides for binding to MHC class II molecules. When added to an antigenic peptide presentation model system, IiP25 inhibited T cell activation by competing for the CLIP binding site at the plasma membrane. Secretion of a lumenal Ii fragment may represent an additional mechanism to modulate T cell activation by MHC class II molecules.

Mesh:

Substances:

Year:  1999        PMID: 10473581     DOI: 10.1074/jbc.274.37.26266

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation.

Authors:  Maximilian Diehn; Ash A Alizadeh; Oliver J Rando; Chih Long Liu; Kryn Stankunas; David Botstein; Gerald R Crabtree; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

2.  A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance.

Authors:  Arthur A Vandenbark; Roberto Meza-Romero; Gil Benedek; Shayne Andrew; Jianya Huan; Yuan K Chou; Abigail C Buenafe; Rony Dahan; Yoram Reiter; Jeffery L Mooney; Halina Offner; Gregory G Burrows
Journal:  J Autoimmun       Date:  2012-09-29       Impact factor: 7.094

3.  Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice.

Authors:  Kalanithi Nesaretnam; Roberto Ambra; Kanga Rani Selvaduray; Ammu Radhakrishnan; Karin Reimann; Ghazali Razak; Fabio Virgili
Journal:  Lipids       Date:  2004-05       Impact factor: 1.880

4.  The role of macrophage migration inhibitory factor in autoimmune liver disease.

Authors:  David N Assis; Lin Leng; Xin Du; Clarence K Zhang; Gerrit Grieb; Melanie Merk; Alvaro Baeza Garcia; Catherine McCrann; Julius Chapiro; Andreas Meinhardt; Yuka Mizue; David J Nikolic-Paterson; Jürgen Bernhagen; Marshall M Kaplan; Hongyu Zhao; James L Boyer; Richard Bucala
Journal:  Hepatology       Date:  2013-12-20       Impact factor: 17.425

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.